Fractional Excretion of Sodium (FENa) [Updated]
Evidence to Action: Official Journal of MDCalc · 2024
DOI: 10.65357/001c.143123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence to Action: Official Journal of MDCalc, 2024. Verfasst von Megan Soliman und 1 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Fractional Excretion of Sodium (FENa) quantifies the proportion of filtered sodium that is excreted in the urine and is widely used to help distinguish between different causes of acute kidney injury (AKI), particularly in oliguric patients. FENa provides a more reliable measure of renal sodium handling than urine sodium concentration alone, as it accounts for urine volume and the influence of antidiuretic hormone. Despite its utility, FENa interpretation requires careful consideration of the clinical context, as low values may also occur in non-volume-depleted states such as glomerulonephritis, hepatorenal syndrome, and cardiorenal syndrome. FENa is best applied in oliguric AKI patients without confounding factors such as diuretic use, chronic kidney disease, urinary tract obstruction, or acute glomerular diseases. No absolute FENa value can definitively diagnose pre-renal AKI, and serial measurements may provide additional diagnostic insight. The physiologic rationale for using a FENa
Zitieren
APA
Soliman, M., & Nair, D. (2024). Fractional Excretion of Sodium (FENa) [Updated]. Evidence to Action: Official Journal of MDCalc. https://doi.org/10.65357/001c.143123
Vancouver
Soliman M, Nair D. Fractional Excretion of Sodium (FENa) [Updated]. Evidence to Action: Official Journal of MDCalc. 2024. doi:10.65357/001c.143123
BibTeX
@article{Soliman2024,
author = {Soliman, Megan and Nair, Devika},
title = {Fractional Excretion of Sodium (FENa) [Updated]},
journal = {Evidence to Action: Official Journal of MDCalc},
year = {2024},
doi = {10.65357/001c.143123}
}
EUVIMED